RA CAPITAL MANAGEMENT, L.P.
Q2 2025 13F Holdings
- Locationboston, MA
- Num holdings
63
- Value ($000)
$5,935,681
- Date Filed08/14/2025
- Form type13F-HR
- CIK0001346824
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
ASND ASCENDIS PHARMA A/S - ADR | SH | 04351P101 | $1.77B | 30 % | 10,281,496 | ||
PCVX VAXCYTE INC | SH | 92243G108 | $389.01M | 7 % | 11,965,991 | ||
RYTM RHYTHM PHARMACEUTICALS INC | SH | 76243J105 | $351.42M | 6 % | 5,561,359 | ||
JANX JANUX THERAPEUTICS INC | SH | 47103J105 | $258.48M | 4 % | 11,189,693 | ||
RNA AVIDITY BIOSCIENCES INC | SH | 05370A108 | $206.36M | 4 % | 7,266,031 | ||
ACLX ARCELLX INC | SH | 03940C100 | $199.96M | 3 % | 3,036,527 | ||
ETNB 89BIO INC | SH | 282559103 | $195.32M | 3 % | 19,889,683 | ||
ARS PHARMACEUTICALS INC | SH | 82835W108 | $189.52M | 3 % | 10,860,977 | ||
NEWAMSTERDAM PHARMA CO NV | SH | N62509109 | $183.62M | 3 % | 10,138,938 | ||
SIONNA THERAPEUTICS INC | SH | 829401108 | $181.23M | 3 % | 10,445,322 |
Rows Per Page
10
- 10
- 50
- 100